β³ Fetching live dividend data...
Home βΊ Calculator βΊ CTKB Dividend Calculator 2026
Cytek Biosciences, Inc. Β· NASDAQ
Price: $3.57 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in CTKB β $17.13M in 10 years Β· $780.44/month
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open CTKB position with:
Real after-tax yield depends on where you live and how you hold CTKB.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 56.02% | 53.22% | $5,602 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 47.62% | 44.82% | $4,762 / yr |
| πΊπΈ US Taxable (20%) | 20% | 44.82% | 42.02% | $4,482 / yr |
| π¬π§ UK ISA | 0% | 56.02% | 53.22% | $5,602 / yr |
| π¬π§ UK Taxable | 8.75% | 51.12% | 48.32% | $5,112 / yr |
| π¨π¦ TFSA | 0% | 56.02% | 53.22% | $5,602 / yr |
| π¨π¦ CA Taxable | 25% | 42.02% | 39.22% | $4,202 / yr |
| π¦πΊ Super (pension) | 15% | 47.62% | 44.82% | $4,762 / yr |
| π¦πΊ AU Taxable | 30% | 39.21% | 36.41% | $3,921 / yr |
| π©πͺ DE Taxable | 26.375% | 41.24% | 38.44% | $4,124 / yr |
| π«π· FR Taxable | 30% | 39.21% | 36.41% | $3,921 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
CTKB pays quarterly β 4 times per year. Next ex-div: TBD.
How CTKB compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CTKB sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-05-18 | 1,454 | β | β | ||
| M-Exempt | 2026-05-18 | 1,454 | β | β | ||
| M-Exempt | 2026-05-18 | 6,107 | β | β | ||
| M-Exempt | 2026-05-18 | 6,107 | β | β | ||
| M-Exempt | 2026-05-18 | 9,480 | β | β | ||
| F-InKind | 2026-05-18 | 2,364 | $3.55 | $8.4K | ||
| M-Exempt | 2026-05-18 | 4,108 | β | β | ||
| F-InKind | 2026-05-18 | 1,025 | $3.55 | $3.6K | ||
| M-Exempt | 2026-05-18 | 3,683 | β | β | ||
| F-InKind | 2026-05-18 | 919 | $3.55 | $3.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CTKB dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β